PetMed Express, Inc. (NASDAQ:PETS) Shares Sold by Hotchkis & Wiley Capital Management LLC

Hotchkis & Wiley Capital Management LLC trimmed its position in PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 15.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,090,703 shares of the company's stock after selling 204,590 shares during the quarter. Hotchkis & Wiley Capital Management LLC owned about 5.28% of PetMed Express worth $4,014,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Sei Investments Co. lifted its stake in shares of PetMed Express by 8.3% during the 2nd quarter. Sei Investments Co. now owns 44,220 shares of the company's stock valued at $179,000 after buying an additional 3,400 shares in the last quarter. Point72 DIFC Ltd bought a new stake in PetMed Express during the 2nd quarter valued at approximately $34,000. Vanguard Group Inc. boosted its stake in PetMed Express by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 1,186,485 shares of the company's stock worth $5,683,000 after purchasing an additional 9,226 shares during the period. Marshall Wace LLP purchased a new position in shares of PetMed Express in the second quarter worth $46,000. Finally, SG Americas Securities LLC bought a new position in shares of PetMed Express during the second quarter worth $46,000. Hedge funds and other institutional investors own 73.33% of the company's stock.

Insider Activity at PetMed Express

In related news, major shareholder Nina Capital Holdings Inc. purchased 12,500 shares of PetMed Express stock in a transaction dated Monday, September 9th. The stock was purchased at an average cost of $3.34 per share, with a total value of $41,750.00. Following the transaction, the insider now owns 2,078,000 shares in the company, valued at approximately $6,940,520. The trade was a 0.61 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.10% of the stock is owned by company insiders.

PetMed Express Stock Performance

PETS stock traded up $0.44 during midday trading on Friday, reaching $5.75. 549,165 shares of the company traded hands, compared to its average volume of 338,296. The firm has a market capitalization of $118.80 million, a price-to-earnings ratio of -95.83 and a beta of 0.71. The business has a 50 day moving average of $4.38 and a 200-day moving average of $3.98. PetMed Express, Inc. has a 52-week low of $2.90 and a 52-week high of $7.90.

PetMed Express (NASDAQ:PETS - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.17. The firm had revenue of $59.57 million for the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. Research analysts anticipate that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

Analysts Set New Price Targets

Separately, StockNews.com raised PetMed Express from a "hold" rating to a "buy" rating in a report on Tuesday, November 12th.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.